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CASE REPORT
Complete laparoscopic-transhiatal removal 
of duplex benign oesophageal tumour: case 
report and review of literature
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Abstract 
Background: Leiomyoma is the most common benign oesophageal tumour. Half of all leiomyoma patients have 
oesophagus-associated complaints, such as dysphagia and epigastric pain, and the other 50% are asymptomatic 
with a diagnosis made on incidental discovery. Endoscopic ultrasonography is essential for an accurate preoperative 
workup and can enable guided-tissue acquisition for immunohistochemistry in certain cases. Smaller tumours are 
amenable to traditional and novel endoscopic removal in specialized centres, but some complex cases require surgi-
cal enucleation with a minimally invasive approach.
Case presentation: An asymptomatic 60-year-old woman was accidentally diagnosed with a bifocal oesophageal 
mass, which was discovered by chest computed tomography. We report a rare case of a duplicated lower-third 
oesophageal leiomyoma, which was completely removed via the laparoscopic transhiatal approach. The patient 
has recovered successfully from the surgery. She has been followed up for six months with a normal oesophagram, 
adequate oesophageal function and no complaints observed. Pathological examination confirmed the diagnosis of 
leiomyoma in both lesions.
Conclusions: To the best of our knowledge, this is the first reported case of duplex oesophageal leiomyomas 
removed laparoscopically. Using the minimally invasive abdominal technique, the lower oesophagus can be mobi-
lised to the mediastinum without pleura injury and offers a good alternative to the thoracoscopic approach in 
patients with possible intrathoracic difficulties. At experienced centres, laparoscopic transhiatal enucleation of lower 
oesophageal leiomyomas and other benign tumours with a combination of intraoperative oesophagoscopy is a safe, 
fast and effective operation.
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Background
Benign oesophageal tumours are rare, with a prevalence 
of less than 0.5% [1], while benign tumours represent 
20% of oesophageal neoplasms on autopsy [2]. Besides 
stromal tumours, granular cell tumours, lipomas and 
schwannomas, oesophageal leiomyoma is one of the most 
common types of benign oesophageal tumours, account-
ing for 80% of nonmalignant cases with male dominance 
[3, 4]. Approximately 50% of patients are asymptomatic 
with a diagnosis made on incidental discovery. When 
symptomatic, symptoms include dysphagia, retrosternal 
pain, heartburn, regurgitation or occasionally upper gas-
trointestinal bleeding and weight loss [5, 6]. In the distal 
oesophagus, leiomyomas may reach a large size [7]. In 
addition to basic examination methods, such as barium 
oesophagraphy, oesophago-gastro-duodenoscopy and 
CT, recently endosonography of the oesophagus is being 
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indicated in all patients. EUS (endoscopic ultrasonogra-
phy—EUS) has provided a major breakthrough for char-
acterizing such masses by identifying the layer of origin 
and enabling guided-tissue acquisition for diagnostic 
studies, including immunohistochemistry. Endosono-
graphically, leiomyomas are typically hypoechoic lesions 
with well-defined margins, although they have irregular 
margins and ulcerations on rare occasions. Preoperative 
biopsy is not generally recommended for a resectable 
lesion, and the patient is otherwise operable. EUS-guided 
biopsy has a variable diagnostic yield ranging from less 
than 20% to more than 90% according to the literature [8, 
9]. However, a biopsy is preferred to confirm the diagno-
sis if advanced disease is suspected. Treatment options 
depend on the characteristics of the lesions. Small epi-
thelial tumours are amenable to endoscopic removal, but 
bigger, lumen-obstructing masses often require surgical 
management. Nowadays, new endoscopic procedures 
are on hand in specialized centres offering a good cura-
tive option for patients with nonmalignant subepithelial 
tumours. Similarly to lower GI (gastrointestinal—GI) 
therapeutic endoscopy, EFTR (endoscopic full thickness 
resection—EFTR) and STER (submucosal tunnelling 
endoscopic resection—STER) have had promising clini-
cal outcomes up to now, but long-term results are lack-
ing. Most cases in the past have been managed with open 
resection, and certain cases call for a partial oesophagec-
tomy with or without isoperistaltic jejunal interposition 
[10]. These patients require prolonged hospitalization 
and a long recovery time. Surgical enucleation using a 
minimally invasive approach represents the gold standard 
treatment in selected patients and is associated with less 
morbidity and a shorter hospital stay compared to thora-
cotomy. The majority of patients undergo a videothoraco-
scopic operation, but in specialized, high-volume upper 
GI institutions the laparoscopic-transhiatal procedure 
could be an alternative method for lower-third lesions. 
We report a successful operation of a duplex oesophageal 
leiomyoma using the laparoscopic-transhiatal approach.
Case presentation
An asymptomatic 60-year-old woman was incidentally 
diagnosed with a twin oesophageal mass, which was sus-
pected due to mediastinal widening on a routine chest 
radiograph. A CT of the thorax discovered the lesions 
with eccentric oesophageal wall thickening in the distal 
third of the oesophagus, causing narrowing of the lumen 
(Fig.  1). Gastroscopy revealed an oesophageal submu-
cosal protrusion with a smooth surface located 32 to 
39 cm from the incisors, close to the Z line. The lesions 
were imaged as separate, 4 × 3 cm and 4 × 2 cm, inhomo-
geneous masses with some calcareous shadows arising 
from the muscularis propria on endoscopic ultrasound 
and were suspected to be leiomyomas because of their 
smooth surfaces and normal colours (Fig. 1). According 
to the NCCN (National Comprehensive Cancer Net-
work—NCCN) Task Force Report, a biopsy may not be 
necessary if the tumour is easily resectable and preopera-
tive therapy is not required [11]. Thus FNA (fine needle 
aspiration—FNA) of the lesions was not performed. The 
results of her physical examination were normal.
Before the scheduled operation, the patient had a his-
tory of a soft diet and received a prophylactic dose of 
LMWH (low-molecular-weight heparin—LMWH) a day 
before surgery. Third-generation cephalosporin and met-
ronidazol were administered one hour before incision; 
then laparoscopic-transhiatal surgery was performed. 
The procedure was done under general anaesthesia with 
the patient in a semilithotomy, 25° reverse Trendelenburg 
position. Three ports were inserted in the abdominal cav-
ity along the left costal arch, with one port placed in the 
epigastrium on the right side and one port, 10–12 mm in 
diameter, inserted directly above the umbilicus (Fig.  2). 
Slightly lower, intraabdominal pressure was set to 12 
Hgmm to prevent pneumomediastinal side-effects. Lapa-
roscopic exploration was done using a 30° camera. After 
retracting the left lobe of the liver, the peritoneum was 
divided up to the level of the median arcuate ligament 
with a Ligasure device (Valleylab, Boulder, CO, USA, 
Fig.  3). A nasogastric tube (size 16 Fr.) was placed into 
the oesophagus to identify its anatomical patterns and to 
avoid oesophageal side injuries. After incision of the hia-
tus (Pinotti’s manoeuvre), the lower third of the oesopha-
gus was mobilised anteriorly; then transhiatal exploration 
revealed that the masses located right under each other 
(oral and aboral tumours) and orally had spread high 
to the middle third of the oesophagus. From the cardia 
side, approximately 3 cm above it, the muscularis of the 
oesophagus was cut in the expected line of myotomy 
to expose the capsule of the aborally located tumour. A 
well-defined solid tumour was revealed with an intact 
capsule and rich blood supply. The lower pole of the abo-
ral tumour along the capsule was gradually isolated and 
removed using fine dissecting instruments and a high-
energy cutting device. The incision was extended until 
it reached the upper edge of the orally located tumour, 
allowing for exploration of the oesophageal mucosa and 
gradual isolation of the tumour outside the mucosa until 
complete tumour resection was achieved. Technically, 
we opened the oesophageal muscle layer approximately 
7–8 cm long, started 3 cm from the cardia and finished 
intramediastinally. The anterior vagal branch was under 
close monitoring and retracted during the entire opera-
tion. The integrity of the mucosal membrane of the 
oesophagus was checked with intraoperative endoscopy; 
the leak test during air insufflation was negative (Fig. 4). 
Page 3 of 7Andrási et al. BMC Gastroenterol           (2021) 21:47  
The oesophageal muscular wall was repaired by absorb-
able 3/0 monofilament sutures. Fundoplication was not 
added because the localisation of the duplex tumour 
was at least 3 cm above the cardia so the natural antire-
flux mechanisms were not compromised during surgery. 
On the other hand, the wrapped segment would have 
formed more distally from the sutured oesophageal wall. 
The specimens were removed in an endobag. The opera-
tion took approximately 120  min to complete (Fig.  5). 
The tumours were approximately 38 × 29 × 27  mm and 
37 × 20 × 30 mm in diameter and tough in quality, with a 
well-defined round shape (Fig. 6). After the operation, the 
patient underwent water fasting, gastrointestinal decom-
pression and acid suppression. Contrast radiography of 
the oesophagus on the fifth postoperative day showed 
intact smooth oesophageal mucosa with no obvious leak-
age, so the nasogastric tube was removed and the patient 
began to consume liquid food. She was discharged on the 
10th postoperative day. She has been followed up for six 
months with a normal swallowing test, adequate oesoph-
ageal function and no complaints observed. A pathologi-
cal examination confirmed the diagnosis of leiomyoma 
in both lesions. Immunohistochemistry resulted nega-
tive for DOG1 (discovered on GIST1—DOG1) and C-kit 
Fig. 1 Computed tomography and endoscopic ultrasonography demonstrating wall thickening of the oesophagus causing stenotisation; photos 
were grouped together
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(CD117) and positive for SMA (smooth muscle actin—
SMA) and desmin. The mitotic rate (Ki-67 index) was 
low. The specimen assessment showed complete removal 
of the two lesions, with no damage to the capsulae seen.
Discussion and conclusions
Surgical excision (enucleation) is recommended for 
symptomatic leiomyomas and those greater than 5  cm. 
Traditionally, tumours of the middle third of the oesoph-
agus are approached using a right thoracotomy; tumours 
in the distal third of the oesophagus are resected through 
a left thoracotomy, with all its associated morbidity [12]. 
While the open surgical technique is still the mainstay 
of therapy for leiomyomas, combined oesophagoscopy 
and video-assisted resection (thoracoscopy and laparos-
copy) are being increasingly performed [13–16]. Because 
of their well-known advantages, thoracoscopic, laparo-
scopic, endoscopic and hybrid procedures have replaced 
Fig. 2 Port site positions
Fig. 3 Dissection of the peritoneum
Fig. 4 Checking mucosal integrity after myotomy
Fig. 5 Intraoperative finding demonstrating a bulky mass above the 
GEJ
Fig. 6 Two completely removed, separated, round leiomyomas
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conventional surgery in specialized centres. Laparo-
scopic-transhiatal enucleation is preferred for lesions in 
the distal third and near the GEJ (gastroesophageal junc-
tion—GEJ) because it provides perfect exposure of the 
lower mediastinum and the upper abdomen, allowing us 
to perform an antireflux repair (anterior—Dor or poste-
rior—Toupet fundoplication). For upper- and middle-
third leiomyomas, the left-sided VATS (video-assisted 
thoracoscopic surgery—VATS) approach is accepted, 
as it provides better exposure and access to the entire 
oesophagus [17, 18]. Jesic et al. and Smith et al. support 
the transhiatal approach for lower oesophageal tumours 
[19, 20].
To the best of our knowledge, this is the first reported 
case of complete laparoscopic transhiatal enuclea-
tion of twin oesophageal leiomyomas. There has been 
no reported case of duplex oesophageal leiomyomas 
removed laparoscopically or thoracoscopically to date. 
If located in the mediastinum, videothoracoscopic enu-
cleation is considered the gold standard approach in 
patients with small-to-medium oesophageal leiomyo-
mas [4]. We have shown that even a more orally located 
leiomyoma can be safely resected through a laparoscopic 
approach in experienced hands. The pathological exami-
nation showed the intact capsulae of the tumours, and 
we have no difficulty preserving the vagal nerve and the 
mucous membrane of the oesophagus. We expected this 
because the patient did not receive a preoperative biopsy, 
which would have made the operation challenging. If 
an oesophageal leiomyoma is suspected, many authors 
do not recommend diagnostic punctures of the lesion. 
When the mucosa appears intact on endoscopy, preop-
erative diagnostic punctures can cause obliteration of 
the layers of the oesophageal wall, resulting in difficulties 
during surgical enucleation and increased risk of mucosal 
perforation and postoperative complications [21, 22]. In 
our patient, the tumours were leiomyomas of the lower 
third, which is the most common location, but duplica-
tion is extremely rare. Endoscopic ultrasonography is the 
preferred modality in the evaluation process and should 
be employed early. In clinical practice, surgical interven-
tion or endoscopic resection is usually recommended to 
prevent excessive growth and related complications [5].
Introduced by pioneers from the Far East, rapid adop-
tion of advanced endoscopic techniques has been 
observed in minimally invasive treatment for oesopha-
geal subepithelial tumours. Using the principles of 
POEM (per-oral endoscopic myotomy—POEM), the 
EFTR method has spread increasingly worldwide. Dur-
ing EFTR, operators cut the mucosa at the level of the 
tumour; submucosal dissection is then performed to free 
the tumour. Muscle fibre dissection is carried out along 
the capsule to remove the lesion; then the defect is closed. 
There is another form of endoscopic resection called 
STER, which was first described by the POEM innova-
tors from China and Japan [23, 24]. STER begins with a 
mucosal incision a few centimeters above the tumour, 
continues with tunnelling around the tumour while sep-
arating it from the mucosa covering it and the muscle 
fibres around it until it is excavated from attachments 
to the muscularis. The mucosal damage is significantly 
less in contrast to EFTR. STER has the great advantage 
of approaching tumours in critical localisation (GEJ and 
gastric antrum), where surgical resection is technically 
challenging [25]. Unlike EFTR, the benefit of STER is 
the closing method compared to a full-thickness defect. 
The vast majority of studies are retrospective data with 
limited follow-up. A recent meta-analysis on STER dem-
onstrated an en bloc resection rate of 94.9%, with over-
all gas-related and inflammation-related adverse events 
rates of 21.5% and 8.4%, respectively, a postinterven-
tional bleeding rate of 2.2%, and length of hospital stay 
of a median of 3.8 days [26]. Wang et al. published excel-
lent outcomes with the STER procedure by successfully 
removing multiple leiomyomas with a mean diameter of 
15 mm in 12 patients [27]. In a prospective, comparative 
study with 66 patients, STER and VATS were investi-
gated. The authors found a shorter procedure time (44.5 
vs. 106.5 min), lower cost ($4499 vs. $5137), less decrease 
in haemoglobin level (0.16 vs. 1.47 g/dL) and lower post-
operative pain scores in the STER group and compara-
ble perioperative clinical outcomes (complete resection 
rate, hospital times and adverse events) between the two 
groups apart from a lower en bloc resection rate for STER 
for subepithelial tumours of ≥ 2 cm (71.4% vs. 100%) [28]. 
STER seems to be a good alternative to surgical resec-
tion in patients with small subepithelial lesions, but even 
dealing with a large size can be safe and feasible [29]. On 
the other hand, EFTR and STER have some contraindi-
cations, including severe comorbidity, sign of advanced-
stage tumour and adjacency to large extra-luminal 
vessels. In planning the endoscopic treatment, there are 
no fixed criteria on the size and location of the lesions; 
it rather depends on the expertise of the operator. How-
ever, tumours bigger than 3–4 cm in the shortest diam-
eter may cause difficulties retracting from the mouth, and 
tumours over 5  cm in the longest diameter have a sig-
nificantly higher risk of malignant potential, with surgery 
thus offering a better outcome. If multiple tumours are 
located at the same level of the oesophagus, endoscopic 
techniques may be challenging and carry significant risk 
of complication even in experienced hands. Due to the 
short follow-up, R1 (microscopic residual disease) cases, 
and possible early recurrences and residual tumours, 
concerns developed among the authors and time will be 
needed to elucidate the role of these novel endoscopic 
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techniques. EFTR and STER, these two frontier endo-
scopic tools, are highly promising, but long-term data are 
missing and prospective randomised studies are lacking.
Robotic surgery could be another highly sophisticated 
treatment option in some referral centres. The procedure 
is safe, provides comparable outcomes to thoracoscopy 
and offers better ergonomics to well-trained surgeons, 
but only in very few, highly selected patients [30, 31]. 
Cerfolio et al. reported four successful leiomyoma resec-
tions using a robotic platform, demonstrating the biggest 
series worldwide in this area [32].
Recently, Asti et  al. reported excellent periopera-
tive and long-term results with a minimally invasive 
approach (thoracoscopic, laparoscopic and endoscopic) 
in 35 patients with leiomyomas near the GEJ. They per-
formed an additional semifundoplication, eliminating 
dependence on the PPI (proton pump inhibitor—PPI) in 
the nonendoscopic group; after a median of 49 months, 
no recurrences and good swallowing function were 
documented [33]. Obuchi et al. performed laparoscopic-
transhiatal enucleation in three cases with a 3.9 cm mean 
tumour size and no major morbidity or mortality. At a 
mean follow-up period of 60.1  months, recurrence was 
not demonstrated [34].
We also prefer the laparoscopic transhiatal approach 
for benign lower-third lesions, and its feasibility was 
demonstrated by our previous study with the transhiatal 
management of epiphrenic oesophageal diverticula [35]. 
In experienced hands, the lower oesophagus can be 
mobilised to the mediastinum without pleura injury. In 
addition, the laparoscopic approach can be advantageous 
in patients with possible intrathoracic adhesions due to 
a history of previous mediastinal inflammation and in 
patients with reduced lung capacity. When the operation 
is combined with intraoperative oesophagoscopy, sev-
eral advantages are on hand: first, localising the tumour 
is easier; second, checking the mucous membrane after 
enucleation can minimize postoperative complications 
[36]. If the tumour is located at least 3 cm above the GEJ, 
GERD (gastroesophageal reflux disease—GERD)-associ-
ated symptoms are lacking and the oesophageal wall can 
be reconstructed successfully; there is therefore no need 
for semifundoplication [37, 38]. Laparoscopic transhiatal 
enucleation of lower oesophageal leiomyomas and other 
benign tumours is a safe, fast and effective operation, and 
offers a good therapeutic alternative to VATS.
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